Dr. Stephen R. Byrn is Charles B. Jordan Professor of Medicinal Chemistry in the Department of Industrial and Physical Pharmacy, Purdue University. Dr. Byrn set in motion the development of the field of Solid State Chemistry of Drugs with his books, short courses, and papers on the subject the first of which were published in the mid-1970’s. He has also educated over 50 Ph. D. students and postdoctoral fellows. Dr. Byrn has had numerous grants including one of the first 13 NIH Centers for AIDS Research. Dr. Byrn is cofounder of Purdue’s graduate programs in regulatory and quality compliance. These programs are now part of the Biotechnology Innovation and Regulatory Science (BIRS) center and MS program at Purdue and in Africa. He is also cofounder of the Sustainable Medicines in Africa project in Tanzania. Dr. Byrn has served as chair of the Pharmaceutical Sciences Advisory Committee to the FDA and chaired several USP committees. Dr. Byrn is also cofounder of SSCI, Inc. (Solid State Chemical Information) and Improved Pharma, LLC. SSCI and Improved Pharma are research and information companies and Improved Pharma, LLC is focusing on providing Synchrotron-based solutions to pharmaceutical problems. Dr. Byrn has taught a range of courses and held several administrative positions in Medicinal Chemistry, Industrial Pharmacy, Physical Pharmacy, and Solid State Chemistry. Dr. Byrn is an elected Fellow of the AAPS, and has received a number of awards for his research and entrepreneurial activities including the AAPS David Grant Award for research, the AAPS Wurster award in pharmaceutics and formulation, and the AAPS award in Global Health. Dr. Byrn also received the Purdue University Morrill Award as the most outstanding faculty member at Purdue in 2018. Dr. Byrn has extensive experience as an expert witness in pharmaceutical patent litigations involving, salts, polymorphs and formulations.
Check back soon for more articles by Stephen R. Byrn, Ph.D.